Spero Therapeutics (SPRO) EBT Margin (QoQ) (2016 - 2026)
Spero Therapeutics (SPRO) EBT Margin (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Spero Therapeutics | 70.14 Mn | 19.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -259,668.00 |
| Dec 31, 2025 | 25,403.00 |
| Sep 30, 2025 | 23,946.00 |
| Jun 30, 2025 | -52,275.00 |
| Mar 31, 2025 | 15.94 Mn |
| Dec 31, 2024 | -24.99 Mn |
| Sep 30, 2024 | -2.48 Mn |
| Jun 30, 2024 | 886,981.00 |
| Mar 31, 2024 | -924,680.00 |
| Dec 31, 2023 | 20,567.00 |
| Sep 30, 2023 | 43,461.00 |
| Jun 30, 2023 | 550,995.00 |
| Mar 31, 2023 | -539,780.00 |
| Dec 31, 2022 | 54,327.00 |
| Sep 30, 2022 | 181,614.00 |
| Jun 30, 2022 | 1.09 Mn |
| Mar 31, 2022 | -1.48 Mn |
| Dec 31, 2021 | 891,588.00 |
| Sep 30, 2021 | -716,927.00 |
| Jun 30, 2021 | -15,252.00 |